MEDICAL DOCTRINE REFERENCE
MEDODVA Recognized Diseases
Selected Diseases and Syndromes Beyond Reliable 24th-Century Cure
Advanced medicine can repair catastrophic injury, replace damaged organs, suppress many infections, and correct numerous genetic defects. MEDODVA nevertheless recognizes a small group of diseases for which no consistently curative therapy exists. These conditions define practical limits for Sirona tissue and organ generation, Panacea autonomous surgery and repair, and Dijit microscopic intervention.
"Sirona replaces, Panacea repairs, and Dijits hunt—but none of them is magic."
A disease may remain incurable when its cause is distributed throughout the genome or nervous system; when lost neural information cannot be reconstructed; when a pathogen hides inside host cells or regenerated tissue; when a target mimics normal human structures; when an exotic contaminant is not alive; or when hostile microscopic machines can disable or evade Dijits.
Veylor's Neural Cascade Syndrome (VNCS)
Progressive neuroarchitectural disorder.
- Origin
- Human; first recognized in long-duration deep-space personnel.
- Cause
- An abnormal regulatory protein produced in a small population of glial cells gradually changes which genes neighboring neurons express, causing the brain to physically reorganize itself around the disease.
- Transmission
- None. Sporadic cases occur, although several hereditary susceptibility alleles are known.
- Symptoms
- Insomnia, phantom smells, unusual emotional responses, short-term memory problems, difficulty recognizing familiar voices, tremors, aphasia, personality changes, hallucinations, loss of spatial awareness, and eventually severe cognitive impairment.
- Progression
- Usually 8–25 years. Long stable periods may be followed by sudden neurological deterioration.
- Diagnostic Method
- Serial neural tomography comparing synaptic architecture over time, supported by cerebrospinal-fluid protein analysis.
- Available Treatment
- Madori therapy for selected psychiatric manifestations; medication to suppress abnormal regulatory protein production; Panacea repair of localized neural injury; neural prosthetics for lost functions.
- Prognosis
- Ultimately fatal without extraordinary intervention. Slowly progressing cases may retain useful function for decades.
- Quarantine Requirements
- None.
Why Sirona, Panacea, or Dijits Cannot Cure It
Sirona can generate healthy neural tissue, but replacing diseased brain structures risks replacing memories, learned behavior, personality, and identity. Panacea cannot reliably infer the patient's original neural architecture after progressive reorganization. Dijits can destroy abnormal cells, but in middle and late disease millions of otherwise living neurons have adopted the altered regulatory state; destroying them would devastate the brain.
Kessarine Intracellular Persistence Disease (KIPD)
Chronic alien intracellular infection.
- Cause
- A microscopic alien organism establishes structures immediately adjacent to the human cell nucleus and incorporates human lipids and proteins into its outer membrane.
- Transmission
- Blood, contaminated surgical equipment, transplanted tissue, and prolonged exposure to infected biological fluids.
- Symptoms
- Recurring fever, fatigue, muscle pain, swollen lymph nodes, anemia, and periodic inflammation of the liver and spleen.
- Progression
- The initial illness resembles a severe viral infection. Symptoms may disappear for years before recurring, with later episodes becoming increasingly difficult to suppress.
- Diagnostic Method
- Specialized intracellular spectroscopy and molecular comparison of suspicious cellular structures. Ordinary immune screening frequently misses the organism.
- Available Treatment
- Combination antimicrobial therapy followed by targeted Dijit treatment. Panacea repairs severe organ damage; Sirona replacement tissue may be used when necessary.
- Prognosis
- Many patients retain normal or near-normal lifespans, but a significant minority develop increasingly frequent relapses.
- Quarantine Requirements
- Blood precautions during dormant disease; full biological isolation during active shedding.
Why Sirona, Panacea, or Dijits Cannot Cure It
The organism covers itself with molecules taken from the host, making it difficult for Dijits to distinguish pathogen from human intracellular structure. Aggressive recognition parameters can cause attacks on healthy cells. Surviving organisms can also infect newly regenerated Sirona tissue.
Sorkovicyst Refractory Complex (SRC)
Chronic cyst-forming disease; includes particularly difficult pulmonary sorkovicyst cases.
- Cause
- A microscopic organism forms extremely durable cysts inside vascularized tissues. Cyst walls incorporate host proteins, calcium compounds, and specialized polymers.
- Transmission
- Varies by strain. Some variants are environmentally acquired; others require exposure to biological fluids.
- Symptoms
- Depend on the affected organ. Pulmonary disease produces declining oxygen exchange, coughing, fatigue, chest pressure, and eventually cardiopulmonary stress.
- Progression
- Cysts slowly accumulate. Treatment destroys most active organisms but rarely eliminates every dormant cyst.
- Diagnostic Method
- Molecular imaging, tissue spectroscopy, blood markers, and microscopic examination.
- Available Treatment
- Antimicrobial cycles, surgical removal of accessible cyst concentrations, respiratory support, Panacea-assisted repair, and eventual organ replacement when necessary.
- Prognosis
- Highly variable. Some patients remain stable for decades; aggressive pulmonary variants may eventually become fatal.
- Quarantine Requirements
- Only for transmissible strains during active shedding.
Why Sirona, Panacea, or Dijits Cannot Cure It
Dormant cysts possess almost no detectable metabolism and may not be recognized as viable targets by Dijits. Sirona can replace damaged organs, but microscopic cysts elsewhere in the body can later colonize replacement tissue.
Rhosvenolyte Incorporation Syndrome (RIS)
Exotic-compound disease.
- Cause
- Chronic exposure to certain improperly stabilized forms of rhosvenolyte allows exotic particles and molecular fragments to become incorporated into bone marrow and connective tissue.
- Transmission
- None.
- Symptoms
- Bone pain, anemia, unusual skin discoloration, vascular fragility, immune abnormalities, spontaneous bruising, and eventual multiple-organ complications.
- Progression
- Slow and cumulative. Symptoms may not appear until years after exposure.
- Diagnostic Method
- Specialized particle spectroscopy detecting characteristic rhosvenolyte-associated signatures inside tissues.
- Available Treatment
- Chelation-like molecular extraction, marrow replacement, regenerative therapy, vascular repair, and organ replacement.
- Prognosis
- Mild exposure is manageable; severe exposure can substantially shorten life.
- Quarantine Requirements
- None, although contaminated patients undergo decontamination before entering ordinary medical facilities.
Why Sirona, Panacea, or Dijits Cannot Cure It
The foreign material is not alive and cannot be killed by Dijits. Some fragments become physically incorporated into extracellular matrices. Sirona replacement can remove localized damage, but widespread disease may involve skeleton, marrow, connective tissue, and vascular systems simultaneously.
Pelagic Glass Fever
Alien environmental pathogen.
- Cause
- A silica-associated microorganism from an extrasolar ocean creates microscopic crystalline colonies along human vascular walls.
- Transmission
- Contaminated water or aerosols containing marine droplets. Human-to-human transmission is extremely rare.
- Symptoms
- High fever, intense thirst, joint pain, bloodshot eyes, microscopic internal bleeding, and shimmering deposits visible in retinal vessels.
- Progression
- Acute disease lasts several weeks. Survivors frequently retain dormant colonies.
- Diagnostic Method
- Retinal examination, blood spectroscopy, and polarized microscopic imaging.
- Available Treatment
- Antimicrobials, temperature control, vascular repair, blood filtration, and specialized Dijits.
- Prognosis
- Approximately 90% survival with advanced treatment, although recurrence remains possible.
- Quarantine Requirements
- Strict environmental isolation until three consecutive shedding tests are negative.
Why Sirona, Panacea, or Dijits Cannot Cure It
The organism secretes a sticky polysilicate compound that adheres to Dijit surfaces. Immobilized Dijits accumulate around colonies and become ineffective; excessive Dijit deployment can worsen vascular obstruction. Medical personnel informally call heavily coated units 'candied Dijits.'
Thrishton Exposure Degeneration (TED)
Exotic-radiation/tensor-associated degenerative syndrome.
- Cause
- Rare exposure to unstable Thrishton-density gradients produces subtle alterations in molecular bonding and cellular regulatory structures.
- Transmission
- None.
- Symptoms
- Fatigue, sensory disturbances, irregular heartbeat, muscle weakness, transient visual distortions, endocrine dysfunction, and eventual widespread organ degeneration.
- Progression
- Highly unpredictable. Some victims stabilize permanently; others deteriorate progressively over several years.
- Diagnostic Method
- Molecular-resonance scanning and characteristic abnormalities in tissue spectroscopy.
- Available Treatment
- Removal from the exposure environment, metabolic stabilization, organ regeneration, stem-cell replacement, and treatment of individual complications.
- Prognosis
- Mild cases usually survive. Severe cases remain among the most difficult occupational diseases associated with advanced propulsion environments.
- Quarantine Requirements
- None. Initial isolation is used until infectious or transferable contamination has been excluded.
Why Sirona, Panacea, or Dijits Cannot Cure It
There is no pathogen for Dijits to attack. Damage occurs at enormous numbers of molecular sites throughout otherwise normal cells. Sirona can replace organs, but circulating regulatory molecules and damaged marrow may cause newly generated tissue to become dysfunctional.
Orpheon Blood Machine Syndrome (OBMS)
Archaeotechnological nanomachine infestation.
- Origin
- Ancient ruins on Orpheon, a formerly inhabited world. The civilization that produced the machines remains unknown.
- Cause
- Machines approximately the size of large terrestrial bacteria enter the bloodstream, identify cells according to unknown criteria, and mechanically perforate and dismantle selected cells.
- Transmission
- The machines do not reproduce naturally. Transfer occurs through contaminated blood, archaeological material, medical instruments, or active ruin mechanisms that release additional units.
- Symptoms
- Sudden anemia, bruising, organ inflammation, vascular pain, fever-like immune responses, and progressive tissue destruction.
- Progression
- Variable. Some machines become dormant for years before reactivating.
- Diagnostic Method
- High-resolution metallic-particle tomography and direct microscopic examination.
- Available Treatment
- Magnetic filtration, electromagnetic disruption, blood replacement, surgical removal of heavily contaminated tissue, and experimental hunter-Dijits.
- Prognosis
- Low-level contamination may sometimes be controlled indefinitely. Massive exposure is frequently fatal.
- Quarantine Requirements
- Maximum technological-biological containment. Blood, waste, instruments, clothing, and remains are treated as contaminated archaeological technology.
Why Sirona, Panacea, or Dijits Cannot Cure It
The ancient machines alter movement patterns after encountering Dijits. Some attach to Dijits and damage their manipulators; others remain motionless against vascular walls when hunter units approach. Recovered units appear to contain primitive adaptive algorithms, making the condition a conflict between microscopic machine ecosystems rather than a conventional infection.
Velkara Cellular Harvest Syndrome (VCHS)
Archaeotechnological cellular attack.
- Origin
- Ruins on Velkara, apparently unrelated to the Orpheon archaeological complex.
- Cause
- Microscopic machines selectively dismantle certain human cell types, collect specific organic molecules, and construct microscopic lattices inside the body for an unknown purpose.
- Transmission
- Direct exposure to active archaeological devices. Secondary transfer through blood is theoretically possible but uncommon because the machines usually remain embedded in tissue.
- Symptoms
- Local numbness, geometric discoloration beneath the skin, muscle deterioration, immune collapse, and progressive organ failure.
- Progression
- Begins locally and later spreads along vascular and lymphatic pathways.
- Diagnostic Method
- Panacea imaging detects highly regular geometric structures inconsistent with biological growth.
- Available Treatment
- Surgical excision, localized electromagnetic destruction, organ replacement, and experimental Dijit intervention.
- Prognosis
- Excellent if detected before systemic spread; poor after multiple organ systems contain machine colonies.
- Quarantine Requirements
- Maximum archaeological-contamination protocols.
Why Sirona, Panacea, or Dijits Cannot Cure It
Velkaran machines are approximately the same size as Dijits and appear to recognize them as competitors. They release molecular adhesives that coat Dijits, immobilize appendages, obstruct sensors, and sometimes glue multiple Dijits together. The medical expression 'Dijits versus dijits' arose from these encounters; lowercase 'dijit' is informal slang for hostile microscopic artificial organisms and does not imply a technological relationship to modern medical Dijits.
Merovan Mimetic Virus (MMV)
Alien viral analog.
- Cause
- An extraterrestrial infectious particle reproduces using human cellular machinery while displaying proteins nearly indistinguishable from ordinary human membrane proteins.
- Transmission
- Respiratory droplets, blood, and mucosal contact.
- Symptoms
- Fever, extreme fatigue, enlarged lymph nodes, temporary neurological symptoms, liver inflammation, and periodic vascular lesions.
- Progression
- Acute infection is usually survived. A small reservoir persists and can cause increasingly severe episodes every few years.
- Diagnostic Method
- Comparative proteomic analysis; conventional pathogen-recognition systems frequently classify infected cells as healthy human tissue.
- Available Treatment
- Antiviral combinations, immune modulation, plasma filtration, and carefully restricted Dijit therapy.
- Prognosis
- Usually compatible with decades of survival. Late-stage disease can become refractory to treatment.
- Quarantine Requirements
- Respiratory and biological-fluid isolation during active episodes.
Why Sirona, Panacea, or Dijits Cannot Cure It
MMV creates a fundamental friend-or-foe problem. Narrow Dijit discrimination misses infected cells; broad discrimination destroys healthy human cells because the target presents host-like surface traits.
Drenez Syndrome
Treatment-resistant genetic disease.
- Cause
- Hundreds of interacting regulatory variants distributed across multiple chromosomes. No individual mutation causes the disease.
- Transmission
- Genetic inheritance, with unpredictable penetrance.
- Symptoms
- Progressive muscle weakness, cardiac abnormalities, endocrine instability, reduced cellular energy production, and eventual respiratory weakness.
- Progression
- Symptoms usually appear between ages 30 and 70 and slowly worsen.
- Diagnostic Method
- Whole-genome analysis combined with metabolic testing and family-history modeling.
- Available Treatment
- Gene-expression regulators, cardiac support, muscle regeneration, Panacea intervention, and periodic replacement of severely damaged tissues.
- Prognosis
- Frequently compatible with a long life, but no reliable permanent cure exists.
- Quarantine Requirements
- None.
Why Sirona, Panacea, or Dijits Cannot Cure It
There is no single defective gene to correct. Editing enough interacting variants risks cancers, developmental abnormalities, immune disorders, or new regulatory failures. Sirona-grown organs made from the patient's DNA eventually develop the same underlying disease.
Recurrent Regenerative Mycosis (RRM)
Chronic alien fungal analog.
- Cause
- A microscopic organism produces dormant intracellular spores capable of surviving inside human stem-cell populations.
- Transmission
- Airborne environmental spores.
- Symptoms
- Persistent cough, fever, skin lesions, exhaustion, inflammatory nodules, and eventual multi-organ involvement.
- Progression
- Initial infection is treatable, but recurrences may follow months or years later.
- Diagnostic Method
- Molecular spore assays and deep-tissue spectral imaging.
- Available Treatment
- Antifungal analogues, Dijits, removal of heavily infected tissue, and Sirona regeneration.
- Prognosis
- Usually manageable but almost never considered completely cured.
- Quarantine Requirements
- Negative-pressure isolation during active pulmonary shedding.
Why Sirona, Panacea, or Dijits Cannot Cure It
Dormant spores occupy stem-cell niches and may be carried into tissue samples used by Sirona systems. Unless every source sample is exhaustively screened, regenerated tissue can emerge already containing dormant infection. MEDODVA doctrine summarizes this limitation as: 'Regeneration is not sterilization.'
Alverin Therapeutic Exhaustion Disease (ATED)
Progressive treatment-resistant systemic infection.
- Cause
- An alien microorganism with an extraordinarily high mutation and epigenetic adaptation rate.
- Transmission
- Primarily blood and bodily fluids.
- Symptoms
- Recurrent fever, weight loss, immune dysfunction, anemia, vascular inflammation, neurological complications, and eventual organ failure.
- Progression
- Each treatment initially works, after which the pathogen adapts. Replacement therapies succeed for progressively shorter periods until treatment options are exhausted.
- Diagnostic Method
- Continuous genomic and proteomic monitoring of the pathogen population.
- Available Treatment
- Rotating antimicrobial compounds, immune therapy, engineered antibodies, Dijits, plasma filtration, organ repair, and experimental personalized drugs.
- Prognosis
- Extremely variable. Some patients survive 30–40 years after infection; others exhaust available therapies within five years.
- Quarantine Requirements
- Strict biological-fluid precautions; full isolation during periods of high pathogen concentration.
Why Sirona, Panacea, or Dijits Cannot Cure It
Alverin organisms evolve defenses against the treatment platform itself, including proteins that bind Dijit surfaces, decoy proteins that provoke attacks on harmless targets, intracellular dormant stages, and compounds that interfere with Dijit sensors. Treatment is therefore a continuing evolutionary arms race.
MEDODVA Archaeotechnological Contamination Doctrine
The Orpheon and Velkara syndromes establish that ancient technological sites must be treated as potential biological-contamination zones even when investigators detect no conventional organism. Personnel entering unknown ruins undergo post-exposure blood screening for artificial particulates before leaving containment. Unexplained microscopic machinery recovered from archaeological sites is presumed hazardous until proven otherwise.
The discovery of ruin-associated microscopic machines also altered the historical understanding of medical nanotechnology. Humanity developed Dijits as an advanced therapeutic technology only to discover evidence that unknown civilizations had mastered comparable microscopic machinery long before humans—and had used it for purposes that appear destructive, extractive, defensive, or otherwise incompatible with modern medicine.
Summary of Technology Limitations
Sirona replaces, Panacea repairs, and Dijits hunt—but none of them is magic. The limits above define the frontier of 24th-century medicine — where regeneration, autonomous repair, and microscopic hunters meet the boundaries of identity, information, and the unknown.
